News October 17, 2013 The Secret to Making Board Meetings Suck Less “When I was a young entrepreneur, board meetings were by far the worst days of… Super User Love0
News October 17, 2013 Under Armour launches $25,000 innovation challenge for Armour39 device – Baltimore Business Journal Under Armour Inc. is hunting for the techies that can help the company beef up… Super User Love0
News October 17, 2013 MedImmune leads $12.5M round for new drug aimed at big chemo market – FierceBiotech MedImmune's venture arm has jumped in to lead a $12.5 million round for a Chapel… Super User Love0
News October 16, 2013 QIAGEN Launches Empowered Genome Community, Invites Citizen Scientists and Researchers to Pool and Collaboratively Interpret Human Genomes – MarketWatch QIAGEN N.V. (frankfurt prime standard:QIA) today announced the Empowered Genome Community, which is a first-of-its-kind… Super User Love0
News October 15, 2013 Adventist HealthCare CEO: Don’t drop your company health plan – Washington Business Journal A prominent health system CEO implored the Washington region's employers to not drop their company… Super User Love0
News October 15, 2013 Schekman, Südhof Awarded 2013 Nobel Prize in Physiology or Medicine – Howard Hughes Medical Institute (HHMI.org) The Nobel Assembly at the Karolinska Institute announced today that Randy W. Schekman, a Howard… Super User Love0
News October 15, 2013 Osiris will sell transplant therapy Prochymal and other assets in deal that could top $100M – Washington Post Osiris Therapeutics shares rose Friday morning after the company said it is selling some of… Super User Love0
News October 15, 2013 Biotechnology Boom is Here to Stay, Investors Say – Venture Capital Dispatch – WSJ There have been more than 30 initial public offerings of biotechnology companies so far this… Super User Love0
News October 15, 2013 Intelligent Redesign of Health Care – Robert S. Kaplan, Thomas W. Feeley, Mary L. Witkowski , and Heidi W. Albright – Harvard Business Review The health care industry has survived economically by cross-subsidizing margin shortfalls in one activity with… Super User Love0
News October 15, 2013 MedImmune acquires biotech company Spirogen for $440 million MedImmune, the global biologics research and development arm of AstraZeneca, has acquired Spirogen, a privately-held… Super User Love0